ARQT logo

Arcutis Biotherapeutics (ARQT) CAPEX

annual CAPEX:

$5.14M+$4.71M(+1101.64%)
December 31, 2024

Summary

  • As of today (May 24, 2025), ARQT annual capital expenditures is $5.14 million, with the most recent change of +$4.71 million (+1101.64%) on December 31, 2024.
  • ARQT annual CAPEX is now -77.91% below its all-time high of $23.28 million, reached on December 31, 2022.

Performance

ARQT CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherARQTcash flow metrics

quarterly CAPEX:

$608.00K-$4.39M(-87.84%)
March 31, 2025

Summary

  • As of today (May 24, 2025), ARQT quarterly capital expenditures is $608.00 thousand, with the most recent change of -$4.39 million (-87.84%) on March 31, 2025.
  • ARQT quarterly CAPEX is now -97.35% below its all-time high of $22.96 million, reached on September 30, 2022.

Performance

ARQT quarterly CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherARQTcash flow metrics

TTM CAPEX:

$5.75M+$608.00K(+11.82%)
March 31, 2025

Summary

  • As of today (May 24, 2025), ARQT TTM capital expenditures is $5.75 million, with the most recent change of +$608.00 thousand (+11.82%) on March 31, 2025.
  • ARQT TTM CAPEX is now -75.46% below its all-time high of $23.44 million, reached on June 30, 2023.

Performance

ARQT TTM CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherARQTcash flow metrics

ARQT CAPEX Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+1101.6%--
3 y3 years---
5 y5 years---

ARQT CAPEX Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-77.9%+1101.6%-97.3%>+9999.0%-75.5%+3759.7%
5 y5-year-77.9%+1101.6%-97.3%>+9999.0%-75.5%+3759.7%
alltimeall time-77.9%+1101.6%-97.3%>+9999.0%-75.5%+3759.7%

ARQT CAPEX History

DateAnnualQuarterlyTTM
Mar 2025
-
$608.00K(-87.8%)
$5.75M(+11.8%)
Dec 2024
$5.14M(+1101.6%)
$5.00M(+3396.5%)
$5.14M(+3351.7%)
Sep 2024
-
$143.00K(+2283.3%)
$149.00K(-65.2%)
Dec 2023
$428.00K
$6000.00(-90.6%)
$428.00K(-21.5%)
DateAnnualQuarterlyTTM
Sep 2023
-
$64.00K(-76.8%)
$545.00K(-97.7%)
Jun 2023
-
$276.00K(+236.6%)
$23.44M(+1.2%)
Mar 2023
-
$82.00K(-33.3%)
$23.16M(+0.4%)
Dec 2022
$23.28M
$123.00K(-99.5%)
$23.08M(+0.5%)
Sep 2022
-
$22.96M
$22.96M

FAQ

  • What is Arcutis Biotherapeutics annual capital expenditures?
  • What is the all time high annual CAPEX for Arcutis Biotherapeutics?
  • What is Arcutis Biotherapeutics annual CAPEX year-on-year change?
  • What is Arcutis Biotherapeutics quarterly capital expenditures?
  • What is the all time high quarterly CAPEX for Arcutis Biotherapeutics?
  • What is Arcutis Biotherapeutics TTM capital expenditures?
  • What is the all time high TTM CAPEX for Arcutis Biotherapeutics?

What is Arcutis Biotherapeutics annual capital expenditures?

The current annual CAPEX of ARQT is $5.14M

What is the all time high annual CAPEX for Arcutis Biotherapeutics?

Arcutis Biotherapeutics all-time high annual capital expenditures is $23.28M

What is Arcutis Biotherapeutics annual CAPEX year-on-year change?

Over the past year, ARQT annual capital expenditures has changed by +$4.71M (+1101.64%)

What is Arcutis Biotherapeutics quarterly capital expenditures?

The current quarterly CAPEX of ARQT is $608.00K

What is the all time high quarterly CAPEX for Arcutis Biotherapeutics?

Arcutis Biotherapeutics all-time high quarterly capital expenditures is $22.96M

What is Arcutis Biotherapeutics TTM capital expenditures?

The current TTM CAPEX of ARQT is $5.75M

What is the all time high TTM CAPEX for Arcutis Biotherapeutics?

Arcutis Biotherapeutics all-time high TTM capital expenditures is $23.44M
On this page